Evidence map›Paper›PMID 36817587›Full record

ArticleFrontiers in endocrinology2023

Large parathyroid adenomas: Potential mechanisms to reconcile adenoma size and disease phenotype.

Arti Bhan, Shobana Athimulam, Poonam Kumari, Rimesh Pal, Sanjay Kumar Bhadada, Bernard C Cook, Shijing Qiu, Sudhaker D Rao

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Avoiding overdiagnosis of parathyroid carcinoma.Virchows Archiv : an international journal of pathology · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. A giant parathyroid adenoma: a case report.Journal of medical case reports · 2024
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arti BhanDivision of Endocrinology, Metabolism and Bone and Mineral Disorders, Henry Ford Health, Detroit, MI, United States.
Shobana AthimulamDivision of Endocrinology, Metabolism and Bone and Mineral Disorders, Henry Ford Health, Detroit, MI, United States.
Poonam KumariDepartment of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Rimesh PalDepartment of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Sanjay Kumar BhadadaDepartment of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Bernard C CookDepartment of Pathology and Laboratory Medicine, Henry Ford Health, Detroit, MI, United States.
Shijing QiuBone and Mineral Research Laboratory, Henry Ford Health, Detroit, MI, United States.
Sudhaker D RaoDivision of Endocrinology, Metabolism and Bone and Mineral Disorders, Henry Ford Health, Detroit, MI, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parathyroid adenomas weighing more than 3.5 g are reported variously as "atypical", "large" or "giant" parathyroid adenomas. All such adenomas are rare variants accounting for no more than 1.5% of all parathyroid adenomas. Large parathyroid adenomas are often associated with more severe form of the disease, including osteitis fibrosa cystica (OFC) and share many biochemical, histological, and molecular features of both benign and malignant parathyroid neoplasms, and are considered a distinct clinical entity. However, the pathogenesis of oversized parathyroid adenomas and the often-associated skeletal phenotype remains unclear. We present 5 cases of primary hyperparathyroidism (PHPT) with OFC, an uncommon manifestation of contemporary PHPT, associated with larger parathyroid adenomas, seen in the Bone and Mineral Disorders Clinic of the Henry Ford Health in the last 30 years to illustrate the critical role of vitamin D nutrition in the pathogenesis of both the OFC and adenoma size. The estimated prevalence of OFC was very low 0.2%, 5 of the >3000 surgically confirmed cases of PHPT seen during this time. The mean ± SD values were: age: 36.8 ± 22.1 years (4 of the 5 <36years), serum calcium 11.6 ± 1.1 mg/dl, alkaline phosphatase 799 ± 487 IU/L, PTH 1440 ± 477 pg/ml, 25-hydroxyvitamin D 13.0 ± 8.9 ng/ml, 1,25-dihyroxyvitamin D 26.5 ± 13.7 pg/ml, urine calcium 562 ± 274 mg/day, and parathyroid adenoma weight 4.53 ± 2.2 g. Parathyroidectomy led to the resolution of both the biochemical indices and OFC in each patient without recurrence over >10 years of follow-up. Because OFC is a very rare in the West, but very common areas of endemic vitamin D deficiency, we also examined the relationship between vitamin D nutrition, as assessed by serum 25-hydroxyvitamin D level, and parathyroid adenoma weight as well as prevalence of OFC in two large secularly diverse cohorts of patients with PHPT (Detroit, USA and Chandigarh, India). Based on this relationship and the relative prevalence of OFC in these two large cohorts, we propose that vitamin D nutrition (and perhaps calcium nutrition) best explains both the adenoma size and prevalence of OFC.

Indexed as

AdenomaOsteitis Fibrosa CysticaParathyroid NeoplasmsCalcifediolCalciumHumansParathyroid HormonePhenotypeVitamin DCalcifediolCalciumParathyroid HormoneVitamin Datypical parathyroid adenomasgiant parathyroid adenomalarge parathyroid adenomasosteitis fibrosa cysticaprimary hyperparathyroidismvitamin deficiencyvitamin D nutrition

Identifiers

PMID36817587
PMCPMC9931720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.